Health Affairs August 18, 2020
Anand Shah, Peter Marks, Stephen Hahn

The COVID-19 pandemic has significantly disrupted society, with necessary social distancing measures to reduce the risk of transmission resulting in the closure of businesses, schools, and other aspects of daily life. To help protect individuals from infection and support a return to normal, the United States government is focused on supporting the development of a vaccine for COVID-19. However, vaccine development, even under normal circumstances, is an arduous endeavor.

Given that recent polling indicates evidence of vaccine hesitancy among Americans for COVID-19, it is also necessary for public health officials to offer reassurance that any potential vaccine will be safe and effective. The Food and Drug Administration (FDA) has taken two key steps on this matter. First, the agency...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
CDC: Thanks in part to fewer COVID-19 deaths, life expectancy rises slightly from 2021 to 2022
The art of the pandemic
Report recommends strengthening U.S. readiness for smallpox, related threats
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
Drinking water linked to 214 outbreaks in 5 years: CDC

Share This Article